Cyclosporine Treatment of Angioimmunoblastic T-Cell Lymphoma Relapsed After an Autologous Hematopoietic Stem Cell Transplant

被引：7
|
作者：
Wang, Xianxuan [1 ]
Zhang, Duanzhong [1 ]
Wang, Li [1 ]
Huang, Jing [1 ]
Yang, Zesong [1 ]
Wang, Jianyu [1 ]
Chen, Jianbin [1 ]
Liu, Lin [1 ]
机构：
[1] Chongqing Med Univ, Affiliated Hosp 1, Dept Hematol, Chongqing, Peoples R China
来源：
EXPERIMENTAL AND CLINICAL TRANSPLANTATION | 2015年 / 13卷 / 02期
基金：
中国国家自然科学基金;
关键词：
Peripheral T-cell lymphoma; Relapse; Therapy;
D O I：
10.6002/ect.2013.0265
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
An angioimmunoblastic T-cell lymphoma is a unique type of peripheral T-cell lymphoma; it has an aggressive course and a poor prognosis. There is no standard therapy for angioimmunoblastic T-cell lymphoma, especially for refractory or relapsed cases. Here, we report a case of 53-year-old woman with angioimmunoblastic T-cell lymphoma who underwent high-dose chemotherapy with an autologous hematopoietic stem cell transplant after several cycles of chemotherapy, but soon relapsed with severe autoimmune hemolytic anemia. The patient was given dexamethasone and thalidomide, but responded poorly; however, she responded well to cyclosporine and finally achieved a sustained response. Thus, we conclude that cyclosporine has an effect in relapsed angioimmunoblastic T-cell lymphoma after an autologous hematopoietic stem cell transplant.
引用
收藏
页码：203 / 205
页数：3
相关论文
共 50 条
  • [31] Reduced intensity conditioning allogeneic hematopoietic stem cell transplant could be beneficial to angioimmunoblastic T-cell lymphoma patients with hemophagocytic lymphohistiocytosis
    Jui-Ting Yu
    Wen-Li Hwang
    Ren-Ching Wang
    Chieh-Lin Teng
    Annals of Hematology, 2012, 91 : 805 - 807
  • [32] Complete remission in a patient with relapsed angioimmunoblastic T-cell lymphoma following treatment with bevacizumab
    Bruns, I
    Fox, F
    Reinecke, P
    Kobbe, G
    Kronenwett, R
    Jung, G
    Haas, R
    LEUKEMIA, 2005, 19 (11) : 1993 - 1995
  • [33] Complete hematologic response after belinostat treatment and allogeneic stem cell transplantation for multiple relapsed/refractory angioimmunoblastic T-cell lymphoma: A case report
    Camus, Vincent
    Etancelin, Pascaline
    Drieux, Fanny
    Veresezan, Elena-Liana
    Picquenot, Jean-Michel
    Penther, Dominique
    Viennot, Mathieu
    Ruminy, Philippe
    Contentin, Nathalie
    Lemasle, Emilie
    Lepretre, Stephane
    Dubois, Sydney
    Penichoux, Juliette
    Stamatoullas, Aspasia
    Zduniak, Alexandra
    Lanic, Helene
    Jardin, Fabrice
    CLINICAL CASE REPORTS, 2023, 11 (06):
  • [34] Treatment of relapsed aggressive adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation with mogamulizumab followed by lenalidomide
    Hayato Tamai
    Kenji Tajika
    Kazutaka Nakayama
    Ayako Arai
    Bone Marrow Transplantation, 2021, 56 : 2862 - 2863
  • [35] Treatment of relapsed aggressive adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation with mogamulizumab followed by lenalidomide
    Tamai, Hayato
    Tajika, Kenji
    Nakayama, Kazutaka
    Arai, Ayako
    BONE MARROW TRANSPLANTATION, 2021, 56 (11) : 2862 - 2863
  • [36] Transmission of angioimmunoblastic T-cell lymphoma by bone marrow transplant
    Kreft, Andreas
    Springer, Erik
    Geissinger, Eva
    Wagner, Eva Maria
    Bender, Klaus
    Kolbe, Karin
    Hainz, Michael
    Rosenwald, Andreas
    Herr, Wolfgang
    Kirkpatrick, Charles James
    Meyer, Ralf Georg
    LEUKEMIA & LYMPHOMA, 2015, 56 (04) : 1164 - 1167
  • [37] Azacytidine and Venetoclax in Relapsed and Refractory Patients With Angioimmunoblastic T-cell Lymphoma
    Laribi, Kamel
    de Materre, Alix Baugier
    Touileb, Yamina
    Boursot, Charles
    Sandrini, Jeremy
    Cavalieri, Doriane
    Pastoret, Cedric
    de Leval, Laurence
    Tournilhac, Olivier
    HEMASPHERE, 2022, 6 (02): : E675
  • [38] Complete remission induced by thalidomide in a case of angioimmunoblastic T-cell lymphoma refractory to autologous stem cell transplantation
    Gottardi, M.
    Danesin, C.
    Stefani, P. M.
    Salvadori, U.
    Zanetti, F.
    Sartor, D.
    Agostini, P.
    Cavallin, S.
    Calistri, E.
    Gherlinzoni, F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 224 - 224
  • [39] Cyclosporine A and Reduced-intensity Conditioning Allogeneic Stem Cell Transplantation for Relapsed Angioimmunoblastic T cell Lymphoma with Hemophagocytic Syndrome
    Matsumura, Yayoi
    Kuroda, Junya
    Shimura, Yuji
    Kiyota, Miki
    Yamamoto-Sugitani, Mio
    Kobayashi, Tsutomu
    Matsumoto, Yosuke
    Horiike, Shigeo
    Taniwaki, Masafumi
    INTERNAL MEDICINE, 2012, 51 (19) : 2785 - 2787
  • [40] Treatment of T-cell anaplastic large cell lymphoma (ALCL) relapsing after autologous stem cell transplant (ASCT) with denileukin difitox (Ontak®).
    Mehta, AC
    Hutchison, RE
    Himpler, BS
    Zamkoff, KW
    Gentile, TC
    BLOOD, 2002, 100 (11) : 308B - 308B
12345